首页> 美国卫生研究院文献>Disease Markers >eNOS 4a/b Polymorphism and Its Interaction with eNOS G894T Variants in Type 2 Diabetes Mellitus: Modifying the Risk of Diabetic Nephropathy
【2h】

eNOS 4a/b Polymorphism and Its Interaction with eNOS G894T Variants in Type 2 Diabetes Mellitus: Modifying the Risk of Diabetic Nephropathy

机译:eNOS 4a / b多态性及其与eNOS G894T变异在2型糖尿病中的相互作用:改变糖尿病性肾病的风险

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

To investigate the possible association between eNOS 4a/b polymorphism and the risk of developing type 2 diabetes mellitus (T2DM) and diabetic nephropathy (DN) 173 T2DM patients with and without DN and 101 healthy subjects with ethnic background of Kurds were examined for the frequency of eNOS variants using PCR-RFLP method. The frequency of eNOS 4a/b genotypes between T2DM and controls was not significantly difference. Studying eNOS 4a/b variants alone indicated that the presence of eNOS 4a allele was not associated with the risk of developing DN. However, considering both polymorphisms of eNOS 4a/b and G894T indicated that the risk of macroalbuminuria significantly increased in the presence of either eNOS 4a or 894T allele by 2.45 times (p=0.014) and 3.7-fold (p=0.016), respectively. However, the concomitant presence of both alleles was not associated with the risk of macroalbuminuria. In microalbuminuric patients, in the presence of each allele, the risk of microalbuminuria increased 2.2 times (p=0.028) and 2.72-fold (p=0.057) for eNOS 4a and 894T alleles, respectively. However, the combined presence of both eNOS 894T and 4a alleles was not associated with the risk of microalbuminuria. The present study indicates the absence of association between eNOS 4a/b variants and the risk of developing T2DM and DN. Also, we demonstrated that eNOS 4a or 894T allele alone increased the risk of developing DN but this effect was modified by the concomitant presence of both alleles.
机译:为了研究eNOS 4a / b多态性与2型糖尿病(T2DM)和糖尿病性肾病(DN)患病风险之间的可能联系,研究了173名患有和未患有DN的T2DM患者以及101名具有库尔德族裔背景的健康受试者PCR-RFLP方法检测eNOS变体。 T2DM与对照组之间eNOS 4a / b基因型的频率没有显着差异。单独研究eNOS 4a / b变体表明,eNOS 4a等位基因的存在与发生DN的风险无关。但是,同时考虑eNOS 4a / b和G894T的多态性表明,存在eNOS 4a或894T等位基因时,大白蛋白尿的风险分别增加了2.45倍(p = 0.014)和3.7倍(p = 0.016)。但是,两个等位基因的同时存在与巨蛋白尿的风险无关。在微白蛋白尿患者中,在每个等位基因的存在下,eNOS 4a和894T等位基因的微白蛋白尿风险分别增加2.2倍(p = 0.028)和2.72倍(p = 0.057)。但是,eNOS 894T和4a等位基因的共同存在与微量蛋白尿的风险无关。本研究表明,eNOS 4a / b变体与发展为T2DM和DN的风险之间没有关联。同样,我们证明了单独使用eNOS 4a或894T等位基因会增加发生DN的风险,但同时存在两个等位基因会改善这种影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号